Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy
| Autor: | Brandt, Claudia, Seja, Patricia, Töllner, Kathrin, Römermann, Kerstin, Hampel, Philip, Kalesse, Markus, Kipper, Andi, Feit, Peter W., Lykke, Kasper, Toft-Bertelsen, Trine Lisberg, Paavilainen, Pauliina, Spoljaric, Inkeri, Puskarjov, Martin, MacAulay, Nanna, Kaila, Kai, Löscher, Wolfgang |
|---|---|
| Zdroj: | In Neuropharmacology December 2018 143:186-204 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect